Cite
HARVARD Citation
Loriot, Y. et al. (2020). Safety and efficacy of atezolizumab in patients with autoimmune disease: Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma. European journal of cancer. pp. 202-211. [Online].